Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease. - Wikidata - awgldk - TriplyDB

Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.

Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.

http://www.wikidata.org/entity/Q34474985

about

Green Tea Epigallocatechin-3-Gallate Suppresses Autoimmune Arthritis Through Indoleamine-2,3-Dioxygenase Expressing Dendritic Cells and the Nuclear Factor, Erythroid 2-Like 2 Antioxidant Pathway.Respiratory Tract Infections, Nonsteroidal Anti-inflammatory Drugs and Acute Myocardial Infarction: Is Understanding Interaction Between Risk Factors the Key to Personalizing Prevention?Novel 4-methylsulfonylphenyl derivatives as NSAIDS with preferential COX-2 inhibition.Prostacyclins in Cardiac Surgery: Coming of Age.Repercussion of nonsteroidal anti-inflammatory drugs on the gene expression of human osteoblasts

P2860

Q36062141-60C86E79-6973-4F99-BAFB-029DFFD5502E Q39579526-DE4D227F-E2B1-4AA6-8DB0-FE8A4FFE797C Q47784462-14454EA3-FC55-4E12-BBB6-AEB8B39533FD Q49582010-11E78333-F421-4267-91B9-6339B6C289D2 Q58782058-2D846809-2F63-41E7-B130-07EA7F7A5D2E

P2860

Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.

http://www.wikidata.org/entity/Q34474985

description

2015 nî lūn-bûn

@nan

2015 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.

@ast

Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.

@en

Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.

@nl

type

label

Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.

@ast

Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.

@en

Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.

@nl

prefLabel

Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.

@ast

Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.

@en

Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.

@nl

P1433

Q34474985-82802131-73A1-4F71-A345-2102030A71D9

P1476

Q34474985-318E7104-4484-4AA3-ABB7-4F097C813952

P2093

Q34474985-541EB1EA-EBB5-441E-B325-AFC6BF2827C4

Q34474985-70336C7C-1D39-4D96-8A2B-59F256CEC58C

Q34474985-9A9DE745-CA95-4D6B-B08A-332B625DC897

Q34474985-D11637DE-24E8-449F-8C84-EAF7B5F96FD9

P2860

Q34474985-051697E8-BA36-4B56-AA9D-3A144F688B05

Q34474985-0DFA25F8-4261-4E2C-AB09-F5DCEAB747AD

Q34474985-1AA728D4-54E5-44D1-8A08-AC649DAA98AD

Q34474985-1B40EE00-D156-48DE-87B5-8733B362E675

Q34474985-1E100453-5184-40A7-A2AB-726508DB27A6

Q34474985-1E8FA3F5-B05F-4CEF-AAE7-49E7AB0E288B

Q34474985-2C1AC11B-B2B7-497E-B589-7A4BA467D7AC

Q34474985-34B7ACDB-5ADC-4A9A-BB98-E6DFC78FF3C2

Q34474985-364710AC-A216-4A15-A2B7-D74AC9DD449C

Q34474985-36EF3ED0-EC83-4A4B-A8F5-B87C80DF7F45

P304

Q34474985-2E34139F-DF33-416E-845D-ED66DAD5859F

P31

Q34474985-D43B30C5-3079-4D56-83EF-6FC902CD74EF

P356

Q34474985-FA7F401C-CCE7-4179-816D-C397B5A7718B

P407

Q34474985-81193E73-E502-4326-9BE8-F62F1FEA134C

P433

Q34474985-A41F93CB-52E5-4EEE-B01F-3864076E4A28

P478

Q34474985-B39F973D-6796-4F24-BAD3-632C8F7A9E10

P50

Q34474985-0D821801-EECF-49B5-A619-0C18D4502A8A

Q34474985-352C7ECD-EF2D-43CB-88F7-925C351803B6

P577

Q34474985-173EEFE4-13A5-49BD-A519-D5ACB1CC38C4

P698

Q34474985-4D2337DD-BEB5-4BAE-A17B-FD0DF873AAA4

P921

Q34474985-0E013AAB-E714-4A23-AFFB-2F3F5A0D99AD

P356

P1433

Pharmacotherapy

P1476

Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease

@en

P2093

Brittany J Tefft

http://www.w3.org/2001/XMLSchema#string

Ilya M Danelich

http://www.w3.org/2001/XMLSchema#string

Jennifer M Lose

http://www.w3.org/2001/XMLSchema#string

Sampaguita S Wright

http://www.w3.org/2001/XMLSchema#string

P2860

Pericardial disease: diagnosis and management

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

Effect of ibuprofen on cardioprotective effect of aspirin

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs

Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.

Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study.

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.

P304

520-535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PHAR.1584

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan D Cicci

P577

2015-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25940579

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease